Soft Tissue Sarcoma Clinical Trials

363 clinical trials for Soft Tissue Sarcoma across international registries, including 83 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• 89Zr-olaratumab Dosimetry in Participants With PDGFR Alpha Positive Solid Tumours and Soft Tissue Sarcoma — RECRUITING · PHASE1
• Novel RNA-lipid Particle (RNA-LP) Vaccine for Anti-PD-1 Antibody Therapy Sensitization — RECRUITING · PHASE1
• Evaluation of Tumor Resection Guided by Intraoperative Indocyanine Green Dye Fluorescence Angiography in Patients With Sarcoma — RECRUITING
• Feasibility Study on the Effect of a Methionine-Reduced Diet on Serum Levels in Pts w/ Solid Tumors — RECRUITING · PHASE1
• Abemaciclib for Bone and Soft Tissue Sarcoma With Cyclin-Dependent Kinase (CDK) Pathway Alteration — RECRUITING · PHASE2
• Phase I Study of JFI447 [68Ga]Ga-DFC413 and Comparison to FFG233 [68Ga]Ga-NNS309 in Patients With Solid Tumors — RECRUITING · PHASE1
• Assessment of the Long-term Efficacy of Moderately Hypofractionated Neoadjuvant Radiotherapy Soft Tissue Sarcoma in the Limbs or Trunk Wall — RECRUITING · PHASE2
• Trial of Single Protein Encapsulated Doxorubicin, SPEDOX-6 in Advanced Malignancies — RECRUITING · PHASE1
• Atezolizumab Plus Tivozanib in Immunologically Cold Tumor Types — RECRUITING · PHASE1
• Circulating Tumor DNA in Soft Tissue Sarcoma — RECRUITING · NA
• Individualized Prehabilitation for Enhancing Recovery and Surgical Outcomes in Patients Undergoing Radiotherapy and Surgery for Soft Tissue Sarcoma — RECRUITING · NA
• Phase I Study of [177Lu]Lu-DFC413 in Patients With Solid Tumors — RECRUITING · PHASE1
• Research of Double-positive Circulating Cells (Tumor Marker / CD45+) in Several Types of Metastatic Cancers — RECRUITING · NA
• Tumor Neoantigen Vaccine SarVac Combined With Tumor Specific Lymphocyte Reinfusion in the Treatment of Advanced Sarcoma — RECRUITING · PHASE1
• Toripalimab Combined With CAV/IE Regimen — RECRUITING · PHASE2
• 5-Day Preoperative Radiation for Soft Tissue Sarcoma — RECRUITING · PHASE2
• A Study to Evaluate Pre-operative HYPOfractionated Radiation Therapy in Aged (≥ 70 Years Old) or "Fragile" (≥ 65 Years) Patients With Limb or Trunk Soft Tissue SARComa. — RECRUITING · PHASE2
• Preoperative Immunonutrition in Patients With Bone and Soft Tissue Sarcomas — RECRUITING · NA
• SATURN-STS: Phase II Study of Neoadjuvant Atezolizumab With Doxorubicin, Concurrent Atezolizumab With Pre-operative Radiation Therapy and Adjuvant Atezolizumab in Patients With High-risk Surgically Resectable Extremity and Truncal Soft Tissue Sarcoma — RECRUITING · PHASE2
• Cryoablation Plus Camrelizumab for Advanced Soft Tissue Sarcoma — RECRUITING · PHASE2
• B7-H3-Specific Chimeric Antigen Receptor Autologous T-Cell Therapy for Pediatric Patients With Solid Tumors (3CAR) — RECRUITING · PHASE1
• Study Assessing the Effects of Early Psychiatric Referral on Mental Health and Quality of Life in People With Sarcoma — RECRUITING · NA
• A Study Evaluating the Safety, Pharmacokinetics and Early Efficacy of AVA6000 in Solid Tumours — RECRUITING · PHASE1
• Safety and Efficacy of DIT309 in Advanced Bone and Soft Tissue Sarcomas — RECRUITING · PHASE1
• A First-In-Human Phase 1 Trial of T-Cell Membrane-Anchored Tumor Targeted Il12 (Attil12)- T-Cell Therapy in Subjects With Advanced/Metastatic Soft Tissue and Bone Sarcoma — RECRUITING · PHASE1
• Spatially Fractionated Radiotherapy Versus Conventional Radiotherapy in the Treatment of Soft Tissue Sarcoma — RECRUITING · NA
• Efficacy and Safety of Envafolimab Plus Doxorubicin and Ifosfamide for Advanced Soft Tissue Sarcoma — RECRUITING · PHASE2
• Phase 2 Trial of Zanzalintinib and Pembrolizumab in Select Subtypes of Advanced/Metastatic Soft-tissue Sarcoma — RECRUITING · PHASE2
• Pre-operative Hypofractionated Proton Therapy — RECRUITING · NA
• Agnostic Therapy in Rare Solid Tumors — RECRUITING · PHASE2
• Application of Contrast-enhanced Ultrasound in Monitoring Soft Tissue Sarcoma Response to Neoadjuvant Radiotherapy — RECRUITING · PHASE1
• Retifanlimab (Anti-PD-1 Antibody) With Gemcitabine and Docetaxel in Patients With Advanced Soft Tissue Sarcoma — RECRUITING · PHASE1
• Interest of Peri Operative CHemotherapy In Patients With CINSARC High-risk Localized Soft Tissue Sarcoma — RECRUITING · PHASE3
• Efficacy and Safety of Cadonilimab Plus Anlotinib in Advanced STS That Failed the Previous First-line Standard Treatment — RECRUITING · PHASE2
• Exercise and Soft Tissue Sarcoma — RECRUITING · NA
• Cirtuvivint in Selected Advanced Soft-Tissue Sarcomas — RECRUITING · PHASE2
• Preoperative 5-Day Radiotherapy for Soft Tissue Sarcoma — RECRUITING · PHASE2
• Trial in Patients With Metastatic or Locally Advanced Leiomyosarcoma — RECRUITING · PHASE2
• IVIM & OLINK in Sarcoma — RECRUITING · PHASE2
• Assessment of the Functional Outcome and Quality of Life in Sarcoma Patients — RECRUITING · NA
• A Clinical Study to Investigate the Efficacy of Intratumoral Tigilanol Tiglate in Soft Tissue Sarcoma — RECRUITING · PHASE2
• BAL Fluid Biomarkers in Sarcoma — RECRUITING · PHASE2
• INPWT on Wound Complications & Clinical Outcomes After Lower Extremity Sarcoma Surgery Preop Radiation Therapy Patients — RECRUITING · NA
• Phase III Trial of Anlotinib, Catequentinib in Advanced Alveolar Soft Part Sarcoma, Leiomyosarcoma, Synovial Sarcoma (APROMISS) — RECRUITING · PHASE3
• Precision Medicine Approaches for Neoadjuvant Therapy in High-risk Sarcoma Patients — RECRUITING
• Multimodal Immune Characterization of RAre Soft Tissue Sarcoma - MIRAS Project From SARRA (SARcome RAre) Project of the French Sarcoma Group — RECRUITING · NA
• HIFU Ablation of Soft Tissue Sarcoma — RECRUITING · NA
• 68Ga-DOTATATE PET/CT for the Diagnosis of Soft Tissue Sarcomas — RECRUITING · NA
• Hypofractionated, 3-week, Preoperative Proton or X-ray Radiotherapy for Patients With Localized Soft Tissue Sarcoma — RECRUITING · PHASE2
• Dose-escalated, Hypofractionated, Definitive Proton Radiotherapy for Patients With Inoperable Soft Tissue Sarcoma. — RECRUITING · PHASE2

Refine this search